fingolimod hydrochloride has been researched along with Canine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeda, S; Matsuki, N; Nakagawa, T; Nakazawa, M; Ohno, K; Yokoyama, N; Yonezawa, T | 1 |
| Enjoji, S; Fujiwara, N; Mizuno, T; Nakagawa, T; Ohama, T; Sato, K; Tsuji, S; Usui, T; Vitek, MP; Yabe, R | 1 |
2 other study(ies) available for fingolimod hydrochloride and Canine Diseases
| Article | Year |
|---|---|
Sphingosine-1-phosphate (S1P) signaling regulates the production of intestinal IgA and its potential role in the pathogenesis of canine inflammatory bowel disease.
Topics: Animals; Dog Diseases; Dogs; Feces; Fingolimod Hydrochloride; Gene Expression; Immunoglobulin A; Inflammatory Bowel Diseases; Intestines; Lysophospholipids; Male; Sphingosine; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors | 2019 |
The therapeutic effects of SET/I2PP2A inhibitors on canine melanoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dog Diseases; Dogs; Fingolimod Hydrochloride; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Chaperones; Melanoma; Neoplasm Proteins; Peptides; Transcription Factors | 2015 |